RLMD icon

Relmada Therapeutics
RLMD

45 hedge funds and large institutions have $265M invested in Relmada Therapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.13M
Puts
$5K
Net Calls
Net Calls Change

Top Buyers

1
+$50.7M
2
+$29.9M
3
+$29.7M
4
RI
RTW Investments
New York
+$25.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$22.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$458K
27
$396K
28
$390K
29
$348K
30
$342K
31
$273K
32
$263K
33
$253K
34
$234K
35
$211K
36
$166K
37
$113K
38
$84K
39
$83K
40
$37K
41
$12K
42
$7K
43
$5K
44
$1K
45
$975
1
2